Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1973 Feb;35(2):211–219. doi: 10.1136/hrt.35.2.211

Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).

K W Walton, G M Craig, P Prior, J A Waterhouse, J Skilton
PMCID: PMC458591  PMID: 4570447

Full text

PDF
211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bollinger A., Simon H. J., Mahlrer F. The natural course of peripheral arteriosclerosis obliterans evaluated by flow measurements. Angiology. 1969 Jul;20(7):414–421. doi: 10.1177/000331976902000705. [DOI] [PubMed] [Google Scholar]
  2. CHAMBERLAIN M. J., GLEESON J. A. AORTOGRAPHY IN THE INVESTIGATION OF HYPERTENSION. Lancet. 1965 Mar 20;1(7386):619–621. doi: 10.1016/s0140-6736(65)91712-5. [DOI] [PubMed] [Google Scholar]
  3. Craig G. M., Walton K. W. Clinical trial of methyl clofenapate (a derivative of clofibrate) in patients with essential hyperlipidaemias--with special reference to type II (primary) hyperlipidaemia. Atherosclerosis. 1972 Mar-Apr;15(2):189–198. doi: 10.1016/0021-9150(72)90069-x. [DOI] [PubMed] [Google Scholar]
  4. Dawson J. M., Raphael M. J. Serial aortography in the study of peripheral vascular disease--a clinical-radiological study. Br J Radiol. 1968 May;41(485):333–340. doi: 10.1259/0007-1285-41-485-333. [DOI] [PubMed] [Google Scholar]
  5. Lykke A. W., Willoughby D. A., Kosche E. R. Thymic permeability factor: its relationship to lymph-node permeability factor and its antagonism by pyridinol carbamate (anginin) and other anti-inflammatory agents. J Pathol Bacteriol. 1967 Oct;94(2):381–388. doi: 10.1002/path.1700940218. [DOI] [PubMed] [Google Scholar]
  6. Mellander S., Johansson B., Gray S., Jonsson O., Lundvall J., Ljung B. The effect of hyperosmolarity on intacet and isolated vascular smooth muscle. Possible role in exercise hyperemia. Angiologica. 1967;4(6):310–322. doi: 10.1159/000157715. [DOI] [PubMed] [Google Scholar]
  7. Piper P. J., Vane J. R. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature. 1969 Jul 5;223(5201):29–35. doi: 10.1038/223029a0. [DOI] [PubMed] [Google Scholar]
  8. Rodbard S., Pragay E. B. Contraction frequency, blood supply, and muscle pain. J Appl Physiol. 1968 Feb;24(2):142–145. doi: 10.1152/jappl.1968.24.2.142. [DOI] [PubMed] [Google Scholar]
  9. Shimamoto T., Atsumi T., Yamashita S., Motomiya T., Isokane N., Ishioka T., Sakuma A. Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans. Am Heart J. 1970 Jan;79(1):5–19. doi: 10.1016/0002-8703(70)90388-1. [DOI] [PubMed] [Google Scholar]
  10. Shimamoto T., Maezawa H., Yamazaki H., Atsumi T., Fujita T., Ishioka T., Sunaga T. Pyridinolcarbamate, a bradykinin antagonist in veins. A preliminary report on pharmacologic and clinical observations. Am Heart J. 1966 Mar;71(3):297–312. doi: 10.1016/0002-8703(66)90469-8. [DOI] [PubMed] [Google Scholar]
  11. Shimamoto T., Sasaki T., Fujita T., Mukai N. The natural history of atherosclerosis. Comparison of aortic lesions in Tokyo, New Orleans, Guatemala and Costa Rica. J Atheroscler Res. 1966 Mar-Apr;6(2):107–119. doi: 10.1016/s0368-1319(66)80016-9. [DOI] [PubMed] [Google Scholar]
  12. Sternieri E., Mucci P., Bertolini A., Castelli M. Variazioni stagionali nella sensibilità alla bradichinina del coniglio e del ratto. Boll Soc Ital Biol Sper. 1969 Apr 15;45(7):421–423. [PubMed] [Google Scholar]
  13. WHITNEY R. J. The measurement of volume changes in human limbs. J Physiol. 1953 Jul;121(1):1–27. doi: 10.1113/jphysiol.1953.sp004926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Whitehead T. P. The computer in the laboratory. Practitioner. 1969 Sep;203(215):294–505. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES